Related Experiment Video
Updated: Mar 5, 2026

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
Published on: November 28, 2016
Molecular diagnosis of Pneumocystis pneumonia in dogs
Patrizia Danesi1, Silvia Ravagnan1, Lynelle R Johnson2
1Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro (PD), Italy.
Abstract:
Pneumocystis pneumonia (PCP) is a life-threatening fungal disease that can occur in dogs. The aim of this study was to provide a preliminary genetic characterisation of Pneumocystis carinii f.sp.'canis' (P. canis) in dogs and thereby develop a reliable molecular protocol to definitively diagnose canine PCP. We investigated P. canis in a variety of lung specimens from dogs with confirmed or strongly suspected PCP (Group 1, n = 16), dogs with non-PCP lower respiratory tract problems (Group 2, n = 65) and dogs not suspected of having PCP or other lower respiratory diseases (Group 3, n = 11). Presence of Pneumocystis DNA was determined by nested PCR of the large and small mitochondrial subunit rRNA loci and by a real-time quantitative polymerase chain reaction (qPCR) assay developed using a new set of primers. Molecular results were correlated with the presence of Pneumocystis morphotypes detected in cytological/histological preparations. Pneumocystis DNA was amplified from 13/16 PCP-suspected dogs (Group 1) and from 4/76 dogs of control Groups 2 and 3 (combined). The latter four dogs were thought to have been colonized by P. canis. Comparison of CT values in 'infected' versus 'colonized' dogs was consistent with this notion, with a distinct difference in molecular burden between groups (CT ≤ 26 versus CT range (26
Insights
This study genetically characterized Pneumocystis in dogs, developing a molecular diagnostic tool for canine Pneumocystis pneumonia (PCP). The new qPCR assay distinguishes infection from colonization, aiding accurate PCP diagnosis in dogs.
Area of Science:
- Veterinary Mycology
- Molecular Diagnostics
- Canine Infectious Diseases
Background:
- Pneumocystis pneumonia (PCP) is a severe fungal infection in dogs, often challenging to diagnose definitively.
- Accurate identification of Pneumocystis carinii f.sp.'canis' (P. canis) is crucial for effective treatment and understanding disease transmission.
- Existing diagnostic methods may lack the specificity and sensitivity required for differentiating infection from colonization.
Purpose of the Study:
- To perform preliminary genetic characterization of P. canis in canine respiratory specimens.
- To develop and validate a reliable molecular protocol for diagnosing canine PCP.
- To differentiate between P. canis infection and colonization in dogs using molecular burden.
Main Methods:
- Investigated P. canis DNA presence in lung specimens from dogs with suspected PCP, non-PCP respiratory issues, and healthy controls using nested PCR.
- Developed and employed a novel real-time quantitative polymerase chain reaction (qPCR) assay targeting specific rRNA loci.
- Correlated molecular findings with cytological/histological detection of Pneumocystis morphotypes and analyzed cycle threshold (CT) values.
Main Results:
- Pneumocystis DNA was detected in 13/16 suspected PCP cases and 4/76 control dogs, suggesting colonization in the latter.
- qPCR demonstrated a significant difference in molecular burden (CT values) between infected (CT ≤ 26) and colonized (26 < CT < 35) dogs.
- Phylogenetic analysis confirmed P. canis as a canine-specific species, validating the qPCR assay's accuracy.
Conclusions:
- The developed qPCR assay is a reliable molecular tool for diagnosing canine PCP.
- The assay effectively distinguishes between Pneumocystis infection and colonization based on molecular burden.
- P. canis is a distinct species specifically associated with dogs, supporting targeted diagnostic and therapeutic strategies.
Related Concept Videos
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia II: Pathophysiology

